Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines ...
Waiver confirms that paediatric studies of certepetide in pancreatic cancer are not needed
Source: eagletribune.com
Cendr Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cendr Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cendr Platform Today - Breaking & Trending Today
Lisata Therapeutics to Present at NobleCon19 Investor Conference
BASKING RIDGE, N.J., Nov. 28, 2023 -- Lisata Therapeutics, Inc. , a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other...
Source: marketscreener.com
Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Malignant Glioma
BASKING RIDGE, N.J., Aug. 08, 2023 -- Lisata Therapeutics, Inc. , a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other...
Source: marketscreener.com
Lisata Therapeutics Announces Enhancements to Ongoing Phase 2b ASCEND Trial of LSTA1
Target enrollment increased to 155 subjects with the addition of a cohort testing a second dose of LSTA1 Results to be used to explore possible conditional approvals globally Futility analysis... | May 24, 2023
Source: marketscreener.com
Lisata Therapeutics, Inc. (LSTA) Q3 2022 Earnings Call Transcript
Lisata Therapeutics, Inc. (NASDAQ:NASDAQ:LSTA) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants John Menditto - VP, IR and Corporate Communications Dave...
Source: seekingalpha.com